With Serena Williams, Amy Schumer, Andy Cohen, Meghan Trainor and more stars giving the various weight loss medicines a shot, ...

Novo Nordisk has had a difficult year: a tumbling stock price resulting in the biggest leadership shakeup in the company's ...

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss pill on Monday, giving the Danish drugmaker a leg ...

Novo’s patent on semaglutide, an active ingredient in weight loss drugs like Wegovy, is set to expire in China in March.

The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

Novo Nordisk shares surged Tuesday after the company said it received FDA approval for an oral version of its injectable weight-loss drug Wegovy.

The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

On Monday evening, the Food and Drug Administration approved Novo Nordisk’s high-dose oral formulation of semaglutide for ...